- Companies
- Ada Health
Ada Health Funding, Investors & Competitors
Ada Health has raised $167M across 3 funding rounds, most recently a $30M Series B in February 2022.
Last Ada Health funding round
$30M
Series B · Feb 2022
Cumulative funding Ada Health raised
$167M
across 3 funding rounds
Key investors in Ada Health
Vitruvian Partners
Leaps by Bayer
Samsung Catalyst Fund
Farallon Capital Management
Bertelsmann
Schroders Capital
Mutschler Ventures AG
Red River West
About Ada Health
Ada Health is a Berlin-based AI health assessment platform founded in 2011. Its app connects users to symptom checkers powered by medical knowledge graphs, available in over 130 countries and 20 languages. Ada partners with health systems like Oxford University Hospitals and non-profits for population health insights.
Founded
2011
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Advertising
Ada Health Funding History
Ada Health has raised a total of $167M across 3 funding rounds, plus 1 secondary share sale.
Ada Health's first fundraising round was a $47M Series A in October 2017. The most recent completed round was a $30M Series B in February 2022.
Ada Health funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Feb 2022 | Series B | Bertelsmann; Farallon Capital Management; Red River West | $30M | Ada Health, a Berlin-based digital health company, develops an AI-powered health assessment and care navigation platform that assists healthcare providers, patients, and consumers in assessing symptoms and navigating care processes. The company announced the closure of its Series B round at $120 million on February 10, 2022, through a $30 million extension led by investors Farallon Capital, Red River West, and Bertelsmann Investments. This followed an initial $90 million Series B raise in May 2021 led by Leaps by Bayer, with participation from Vitruvian Partners, Inteligo Bank, F4, and Mutschler Ventures. The extension funding aims to accelerate Ada's growth, particularly in the US market where it has shown strong commercial traction despite minimal presence, and to further develop its AI solutions, form new partnerships, and build a personalized health operating system. Bertelsmann Investments highlighted Ada as one of its first digital health investments, praising its best-in-class platform and growth potential. Red River West emphasized Ada's US traction and plans to leverage its network of entrepreneurs. Additionally, Schroders Capital became a major investor via a secondary transaction acquiring over $30 million in shares from public and private vehicles. As of February 2022, Ada had registered 11 million users worldwide and was expanding partnerships with companies like Bayer and Novartis while targeting North American health systems. The funding supports continental expansion amid rising demand for digital health solutions. |
| Dec 2021 | Secondary | Schroders Capital | - | Schroder UK Public Private Trust, managed by Schroders Capital, announced on 3 December 2021 that it had acquired €11.8 million of Ada Health shares from existing holders, following the Berlin company's Series B financing led by Leaps by Bayer in May 2021 in which Vitruvian Partners, Samsung Catalyst Fund, Inteligo Bank, F4 and Mutschler Ventures had also taken part. Schroders Capital bought more than $30 million of Ada Health secondary shares in total across its public and private vehicles. The managers argued the investment addressed healthcare's cost, access and quality trade-off by supporting earlier diagnosis and more efficient routing of patients to the right care, and framed it against UN Sustainable Development Goal targets on universal health coverage. Ada Health was founded in 2011 by Claire Novorol, Daniel Nathrath and Martin Hirsch and runs an AI symptom assessment and care navigation platform whose consumer app had drawn more than 11 million users since its 2016 global launch, over a million of them in the UK. The company licenses its technology to health systems, insurers and employers alongside the consumer app. The holding was later written down, contributing negatively to the trust's net asset value in 2025. |
| May 2021 | Series B | Leaps by Bayer (lead); Inteligo; Samsung Catalyst Fund; Mutschler Ventures AG; F4; Vitruvian Partners | $91M | - |
| Oct 2017 | Series A | Vitruvian Partners (lead); June Fund; William Tunstall-Pedoe; Cumberland VC | $47M | Ada Health is a Berlin-based digital health company founded in 2011 that develops an AI-powered symptom assessment and healthcare navigation platform combining medical knowledge with artificial intelligence to provide personalized health insights and triage users to appropriate care. The platform has been used for millions of assessments worldwide and partners with healthcare systems, insurers, life sciences companies, and nonprofits to integrate symptom analysis into digital health offerings. On October 31, 2017, Ada Health raised a Series A round of approximately €40 million (about $47 million USD), led by Vitruvian Partners with participation from June Fund, William Tunstall-Pedoe, Cumberland VC, and others including L&R Ventures. This followed earlier funding like a €2.4M grant in 2015 and an angel round in 2011. The round supported expansion of Ada's health analytics technologies and growth ambitions. User and assessment metrics emerged later; by 2021, Ada reported over 11 million users and 23-24 million assessments since 2016 launch. Subsequent funding included a 2021 Series B of $90 million (later extended to $120 million in 2022) led by Leaps by Bayer, with Vitruvian Partners continuing participation alongside Samsung Catalyst Fund and others, focusing on US expansion, enterprise offerings, and AI development amid digital health growth accelerated by COVID-19. Ada positioned itself for global scale targeting 1 billion users with high clinical accuracy. Competitive context places Ada among leaders in AI-driven digital health navigation, partnering with entities like Bayer and Novartis, while investors like Vitruvian back high-growth tech disruptors across sectors. |
Who has invested in Ada Health?
13 investors have backed Ada Health across its funding rounds, including Vitruvian Partners, Leaps by Bayer, Samsung Catalyst Fund, Farallon Capital Management, Bertelsmann and Schroders Capital.
Lead investors include Leaps by Bayer and Vitruvian Partners.
Ada Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Lead | Oct 2017 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | May 2021 | ||
| 1 | Participant | Oct 2017 | ||
| 1 | Participant | May 2021 | ||
| 1 | Lead | May 2021 | ||
| 1 | Participant | May 2021 | ||
| 1 | Participant | Dec 2021 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Oct 2017 | ||
| 1 | Participant | May 2021 | ||
This data is available for Pro users. Sign up to see all 13 Ada Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAda Health Competitors
Ada Health competitors include listed companies like Nyxoah and Kooth, and private ones like Ro, Sword Health, Noom and Pristyn Care.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $598M | - | $7B | 11.7x | ||
| Private | $240M | - | $4B | 16.7x | ||
| Private | $400M | - | $3.7B | 9.3x | ||
| Private | $64M | - | $1.4B | - | ||
| Publicly listed | $12M | ($97M) | $162M | 3.2x | ||
| Publicly listed | $85M | $13M | $90M | 0.7x |
Ada Health Public Comps
Ada Health is still privately-owned, but its public comps include Max Healthcare Institute, Oscar Health, Hims, Compass Pathways, Alignment Healthcare, Ping An Healthcare, JMDC, GoodRx, Teladoc and Helus Pharma.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $858M | $232M | 12.6x | 10.2x | 46.5x | 36.8x | |||
| $12B | ($391M) | 0.5x | 0.4x | (15.9x) | 12.8x | |||
| $2.3B | $178M | 3.1x | 2.4x | 40.4x | 23.9x | |||
| - | ($293M) | - | - | (5.8x) | (8.4x) | |||
| $3.9B | $45M | 0.4x | 0.3x | 31.6x | 10.0x | |||
| $815M | $52M | 0.9x | 0.9x | 13.4x | 16.9x | |||
| $324M | $88M | 5.0x | 4.6x | 18.4x | 17.9x | |||
| $797M | $173M | 1.8x | 1.8x | 8.1x | 5.5x | |||
This data is available for Pro users. Sign up to see all Ada Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Ada Health
| When was Ada Health founded? | Ada Health was founded in 2011. |
| Where is Ada Health headquartered? | Ada Health is headquartered in Berlin, Germany. |
| Is Ada Health publicly listed? | No, Ada Health is a private, VC-backed company. |
| How much funding has Ada Health raised? | Ada Health has raised $167M across 3 funding rounds. |
| What was Ada Health's last funding round? | Ada Health's last funding round was a $30M Series B in February 2022. |
| Who are Ada Health's investors? | Ada Health's investors include Vitruvian Partners, Bertelsmann, Inteligo, June Fund, Samsung Catalyst Fund, Leaps by Bayer, Mutschler Ventures AG, Schroders Capital, Farallon Capital Management, William Tunstall-Pedoe and 3 others. |
| Which companies are comparable to Ada Health? | Companies comparable to Ada Health include Ro, Sword Health, Noom, Pristyn Care, Nyxoah and Kooth. |
See companies similar to Ada Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




